Veterinary microbiome research increasingly identifies diet-associated microbial taxa, functional genes, metabolites, and dysbiosis patterns. However, detecting a difference does not establish that nutrition should change. Taxonomic composition may diverge from functional capacity; functional potential may not produce measurable metabolites; and metabolite variation may not alter host health, welfare, or production performance. Interpretation is further constrained by species, gastrointestinal compartment, life stage, genotype, disease, medication exposure, production environment, sampling, and analytical method. This original non-empirical article develops a translational framework in which microbiome information modifies nutritional decisions only when it contributes information beyond conventional assessment and changes a feasible clinical or production action. The framework separates microbial measurement, functional interpretation, host-response evidence, decision consequence, and post-intervention reassessment. It proposes that actionability requires a credible connection between a modifiable dietary exposure, a microbiome-mediated or microbiome-indicated process, and an outcome that matters for the animal or production system. Noncompensatory constraints prevent attractive microbial findings from overriding nutritional adequacy, safety, disease-specific requirements, welfare, or practical feasibility. Taxonomic novelty, diversity shifts, predicted pathways, and isolated metabolites remain nonactionable when their direction, persistence, host relevance, or response to diet is uncertain. Potential applications include selecting among otherwise acceptable fibre strategies, interpreting recovery after microbiome-disrupting exposures, and identifying heterogeneous nutritional responses. The framework is not a validated score, diagnostic instrument, or prescribing algorithm. Its use requires species-specific reference resources, standardized measurement, prospective intervention studies, external validation, and evidence that microbiome-informed decisions improve meaningful outcomes compared with decisions made without microbiome information.
